These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6938995)

  • 21. Animal models for the study of cancer-induced anorexia.
    Garattini S; Guaitani A
    Cancer Treat Rep; 1981; 65 Suppl 5():23-35. PubMed ID: 6955017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological approaches to appetite suppression.
    Blundell J
    Trends Pharmacol Sci; 1991 Apr; 12(4):147-57. PubMed ID: 2063481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological approaches to feeding behaviour and eating disorders.
    Willner P; Bergman J; Vanderschuren L
    Behav Pharmacol; 2012 Sep; 23(5-6):439-40. PubMed ID: 22854303
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical pharmacology of appetite suppressant drugs.
    Silverstone T; Goodall E
    Int J Obes; 1984; 8 Suppl 1():23-33. PubMed ID: 6242052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The production of anorexigenic substances by intestinal flora.
    Ohkubo T; Tsuda T; Sawamura S; Katsunuma T; Yamamura M
    Biochem Biophys Res Commun; 1988 Jun; 153(3):1167-72. PubMed ID: 3291869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knocking down the transcript of protein kinase C-lambda modulates hypothalamic glutathione peroxidase, melanocortin receptor and neuropeptide Y gene expression in amphetamine-treated rats.
    Hsieh YS; Yang SF; Chen PN; Chu SC; Chen CH; Kuo DY
    J Psychopharmacol; 2011 Jul; 25(7):982-94. PubMed ID: 20817751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rikkunshito as a ghrelin enhancer.
    Takeda H; Muto S; Nakagawa K; Ohnishi S; Sadakane C; Saegusa Y; Nahata M; Hattori T; Asaka M
    Methods Enzymol; 2012; 514():333-51. PubMed ID: 22975063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenaline anorexia in a cold environment.
    Stevenson JA; Box BM
    Can J Physiol Pharmacol; 1967 May; 45(3):562-4. PubMed ID: 6035176
    [No Abstract]   [Full Text] [Related]  

  • 30. PEGylated cholecystokinin prolongs satiation in rats: dose dependency and receptor involvement.
    Verbaeys I; León-Tamariz F; Buyse J; De Cuyper M; Pottel H; Van Boven M; Cokelaere M
    Br J Pharmacol; 2007 Oct; 152(3):396-403. PubMed ID: 17618299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection.
    Matsuda K; Maruyama K; Miura T; Uchiyama M; Shioda S
    Neurosci Lett; 2005 Sep; 386(1):9-13. PubMed ID: 15975713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracerebral administration of protein kinase A or cAMP response element-binding protein antisense oligonucleotide can modulate amphetamine-mediated appetite suppression in free-moving rats.
    Hsieh YS; Yang SF; Kuo DY
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E123-31. PubMed ID: 16896163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The appetite suppressant d-fenfluramine reduces water intake, but not food intake, in activity-based anorexia.
    Hillebrand JJ; Heinsbroek AC; Kas MJ; Adan RA
    J Mol Endocrinol; 2006 Feb; 36(1):153-62. PubMed ID: 16461935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
    Callahan BT; Yuan J; Ricaurte GA
    Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance P is associated with hypothalamic paraventricular nucleus activation that coincides with increased urotensin 2 mRNA in chicks.
    Mace JD; Tachibana T; Wang G; Newmyer BA; Guilliams E; Gilbert ER; Cline MA
    Neuropeptides; 2014 Oct; 48(5):305-11. PubMed ID: 25005752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Satietin, a blood-borne glycoprotein in the regulation of food intake.
    Knoll J
    Prog Clin Biol Res; 1985; 192():515-22. PubMed ID: 4080718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3.
    Asakawa A; Fujimiya M; Niijima A; Fujino K; Kodama N; Sato Y; Kato I; Nanba H; Laviano A; Meguid MM; Inui A
    Psychoneuroendocrinology; 2010 Sep; 35(8):1178-86. PubMed ID: 20188481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opiate antagonists and eating behavior in humans: a review.
    de Zwaan M; Mitchell JE
    J Clin Pharmacol; 1992 Dec; 32(12):1060-72. PubMed ID: 1487543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Action of a new anorexigenic agent in polyphagic obesity].
    LAMBUSIER P
    Presse Med (1893); 1963 Jan; 71():181-2. PubMed ID: 13928306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.